CXCL13 and neoplasm: Their result proves that human and mouse lung adenocarcinomas pull out the production of tumor-binding antibodies and, moreover, identified endogenous retrovirus (ERV) envelope glycoproteins as a strong anti-tumor antibody target, which probably requires CXCL13-dependent TLS formation [43].